Live from the NIH registry
Studies recruiting near Elkhart right now
Top 25 of 106 recruiting studies, sorted by proximity — each links to its official registry page
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: NRG Oncology
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Breast Cancer, TNBC - Triple-Negative Breast Cancer
N/A
Observational 900 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Tempus AI
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute LAO
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Beacon Children's Hospital — South Bend, Indiana (14.8 mi)
· Sponsor: Children's Hospital of Philadelphia
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Midwest Cardiovascu Rsrch Foundation — Elkhart, Indiana (1.0 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: 89bio, Inc.
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Digestive Research Alliance of Michiana — South Bend, Indiana (14.8 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: Akero Therapeutics, Inc
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Digestive Research Alliance of Michiana — South Bend, Indiana (14.8 mi)
· Sponsor: Eccogene
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity
Phase 2
Interventional 338 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi)
· Sponsor: OHB Neonatology Ltd.
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Lakeland Hospital Niles — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
Mental Health, Conflict
N/A
Interventional 1,800 participants sought
University of Notre Dame — Notre Dame, Indiana (14.2 mi)
· Sponsor: University of Notre Dame
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Elkhart General Hospital — Elkhart, Indiana (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: 89bio, Inc.
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: Children's Oncology Group
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Pancreatic Neoplasm
N/A
Observational 770 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma
Phase 2
Interventional 152 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: NRG Oncology